EPO Patents = 3

Forward Citations = 2

Loading Chart...

34 inventors (with patents filed for the assignee):

Yuquan Li (5 out of 5 patents)

Wei Liu (4 out of 9 patents)

Weiren Xu (4 out of 10 patents)

4. Lida Tang (4 out of 12 patents)

5. Guilong Zhao (3 out of 7 patents)

6. Changying Liu (3 out of 3 patents)

7. Huihui Chen (3 out of 3 patents)

8. Haizhi Zhang (3 out of 3 patents)

9. Xuyuan Liu (3 out of 3 patents)

10. Yuqiang Liu (3 out of 5 patents)

11. Yafei Xie (3 out of 5 patents)

12. Jingwei Wu (3 out of 3 patents)

13. Meixiang Zou (3 out of 6 patents)

14. Qian Shang (2 out of 2 patents)

15. Lei Liu (1 out of 99 patents)

5 patents: Sort by Forward Citations

1. 12257287 - Glucagon-derived peptide and use thereof (2025-03-25),

2. 11466025 - Thienopyridine derivatives containing unsaturated aliphatic olefinic bond, preparation method and use thereof (2022-10-11),

3. 11149013 - Crystal form of urate transporter 1 inhibitor and preparation method and use thereof (2021-10-19),

4. 11091448 - Method for preparing urate transporter 1 inhibitor (2021-08-17),

5. 10584104 - Carboxylic acid URAT1 inhibitor containing diarylmethane structure, preparation method and use thereof (2020-03-10),

Tianjin Institute of Pharmaceutical Research Co., Ltd. is a leading pharmaceutical research and development company based in Tianjin, China. With a focus on innovative drug discovery and development, the company specializes in areas such as oncology, CNS disorders, and cardiovascular diseases. Their team of experienced researchers and scientists work tirelessly to bring cutting-edge treatments to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#53 in Tianjin

#4,587 in China

Tianjin, China

Tianjin Institute of Pharmaceutical Research Co., Ltd.